Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-24 @ 7:11 PM
NCT ID:
NCT04417803
Eligibility Criteria:
Inclusion Criteria:
* Person who has not opposed to their inclusion in the trial
* Confirmation of the diagnosis of one of the lymphomas (DGLBL, LF, classic LH, LT or LCM) according to the WHO 2016 international classification (Smerdlow et al, 2016)
* Patients not currently taking treatment for their haemopathy (or who have received corticosteroid therapy alone within 14 days prior to the 1st sampling, dose limited to 500mg total)
* Patients requiring systemic treatment within 30 days of screening
Exclusion Criteria:
* Person subject to legal protection (curatorship, guardianship)
* Person under partial judicial control
* Pregnant, parturient or breastfeeding woman
* Adult incapable or incapable to express his or her non-opposition
* Minor
* Localized lymphoma treated by surgery and/or localized radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04417803
Study Brief:
Protocol Section:
NCT04417803